Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders with a T- or NK-cell phenotype
- PMID: 31257346
- PMCID: PMC6661958
- DOI: 10.3960/jslrt.19013
Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders with a T- or NK-cell phenotype
Abstract
Other iatrogenic immunodeficiency-associated lymphoproliferative disorders (OIIA-LPDs) with a T- or NK-cell phenotype are markedly rare, with only a limited number of cases having been reported thus far. Methotrexate (MTX) is the most common agent used for OIIA-LPD patients, and 43 cases of MTX-associated T-LPDs (MTX T-LPDs) and five cases of MTX-associated NK/T-LPDs (MTX NK-LPDs) have been described. In addition to MTX T-LPDs and MTX NK/T-LPDs, T-LPD and NK/T-LPDs have been reported in patients receiving other immunosuppressive agents such as thiopurines, TNF antagonists, and cyclosporine. Hepatosplenic T-cell lymphoma (HSTL) is specifically associated with iatrogenic immunodeficiency, and 10% of HSTL cases develop in patients receiving thiopurines and/or TNF antagonists for inflammatory bowel disease (IBD). In this review, we focused on MTX T-LPD, MTX NK/T-LPD, and HSTL in patients with IBD. These T- and NK/T-cell associated OIIA-LPDs are the most common in daily medical practice.
Keywords: T or NK/T-cell lymphoma; hepatosplenic T-cell lymphoma; inflammatory bowel disease; methotrexate; other iatrogenic immunodeficiency-associated lymphoproliferative disorder.
Conflict of interest statement
Figures



Similar articles
-
Clinical management for other iatrogenic immunodeficiency-associated lymphoproliferative disorders.J Clin Exp Hematop. 2019;59(2):72-92. doi: 10.3960/jslrt.19007. J Clin Exp Hematop. 2019. PMID: 31257348 Free PMC article. Review.
-
Clinicopathological findings, prognosis, and Epstein-Barr virus infection in rheumatoid arthritis patients with other iatrogenic immunodeficiency-associated T- and NK-cell lymphoproliferative disorders.BMC Cancer. 2022 Dec 22;22(1):1342. doi: 10.1186/s12885-022-10358-0. BMC Cancer. 2022. PMID: 36544095 Free PMC article.
-
Iatrogenic immunodeficiency-associated lymphoproliferative disorders of B-cell type that develop in patients receiving immunosuppressive drugs other than in the post-transplant setting.J Clin Exp Hematop. 2019;59(2):48-55. doi: 10.3960/jslrt.19014. J Clin Exp Hematop. 2019. PMID: 31257345 Free PMC article. Review.
-
Retrospective analyses of other iatrogenic immunodeficiency-associated lymphoproliferative disorders in patients with rheumatic diseases.Br J Haematol. 2021 Nov;195(4):585-594. doi: 10.1111/bjh.17824. Epub 2021 Sep 23. Br J Haematol. 2021. PMID: 34558064 Free PMC article.
-
The incidence and prognosis of other iatrogenic immunodeficiency-associated lymphoproliferative disorders of the lung related to methotrexate: A retrospective study.Pulm Pharmacol Ther. 2024 Jun;85:102297. doi: 10.1016/j.pupt.2024.102297. Epub 2024 Mar 11. Pulm Pharmacol Ther. 2024. PMID: 38467341
Cited by
-
Cutaneous methotrexate-related T-cell lymphoproliferative disorder with CD4, CD30, CD56, EBV-positive tumor cell infiltration: a case illustration and a brief review.Am J Blood Res. 2021 Apr 15;11(2):163-167. eCollection 2021. Am J Blood Res. 2021. PMID: 34079630 Free PMC article.
-
Primary Cutaneous Methotrexate-Associated T-Cell Lymphoproliferative Disorder in the Setting of Autoimmune Disease: A Case Series and Review of the Literature.Am J Dermatopathol. 2025 Feb 1;47(2):145-152. doi: 10.1097/DAD.0000000000002905. Am J Dermatopathol. 2025. PMID: 39851907 Free PMC article. Review.
-
Atypical lymphoid proliferations associated with therapeutic intervention: a report of the 2024 EA4HP/SH lymphoma workshop.Virchows Arch. 2025 Aug 13. doi: 10.1007/s00428-025-04197-0. Online ahead of print. Virchows Arch. 2025. PMID: 40801926 Review.
-
Primary Skeletal Muscle Peripheral T-cell Lymphoma: An Autopsy Case Report and Review of the Literature.Intern Med. 2021 Oct 15;60(20):3309-3315. doi: 10.2169/internalmedicine.7391-21. Epub 2021 May 7. Intern Med. 2021. PMID: 33967141 Free PMC article. Review.
-
Case report: Cellular therapy for hydroa vacciniforme-like lymphoproliferative disorder in pediatric common variable immunodeficiency with chronic active Epstein-Barr virus infection.Front Immunol. 2022 Aug 5;13:915986. doi: 10.3389/fimmu.2022.915986. eCollection 2022. Front Immunol. 2022. PMID: 35990691 Free PMC article.
References
-
- Swerdlow SH, Campo E, Harris NL, et al. World Health Organization classification of hematopoietic and lymphoid tissue. Revised 4th ed, Lyon, International Agency for Research on Cancer. 2017; pp. 453-464.
-
- Hoshida Y, Xu JX, Fujita S, et al. Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication. J Rheumatol. 2007; 34: 322-331. - PubMed